Treatment profiles

1. Rheumatology disorders, post-traumatic and orthopaedic disorders

•     rheumatoid arthritis, psoriatic arthritis;
•     ankylosing spondylitis;
•     osteoarthritis;
•     spinal disc herniation;
•     osteoporosis;
•     gout;
•     post-traumatic conditions and post-surgery orthopaedic articular and osteal disorders;
•     pathological curvature of the spine.

2. Circulatory system disorders:

•     stable ischaemic heart disease;
•     conditions following cardiac infarction;
•     conditions following surgery on valves and blood vessels;
•     arterial hypertension.

3. Respiratory system disorders:

•     chronic upper respiratory congestion;
•     chronic bronchitis;
•     Chronic Obstructive Pulmonary Disease;
•     conditions following respiratory system inflammations.

4. Nervous system disorders:

•     sciatica and brachial plexus;
•     neuralgias and chronic plexus neuropathies;
•     conditions following stroke;
•     conditions following neurosurgery;
•     multiple sclerosis;
•     Parkinson’s disease;
•     migraines;
•     organ neuroses.

5. Endocrine system disorders and metabolic disorders:

•     controlled diabetes  type I and II;
•     simple obesity and obesity associated with circulatory system disorders, locomotor disorders and lipid metabolism disorders;
•     hypothyroidism and uninodular growth of the goitre (inactive).

6. Dermal disorders:

•     psoriasis;
•     albinism;
•     hyperkeratosis;
•     venous insufficiencies.

7. Other disorders and diseases:

•     post-mastectomy physical rehabilitation.

 

Contraindications for balneological treatment:

•     acute and chronic contagious diseases;
•     full-blown circulatory and respiratory insufficiency;
•     severe hemorrhagic diathesis;
•     psychical disorders, serious mental deficiency;
•     infirmity, complete physical self-service disability;
•     severe urine incontinence;
•     alcoholism and drug addiction;
•     epilepsy with frequent bouts;
•     active malignancy;
•     conditions occurring during surgical or preventive treatment of:

        - kidney tumour, malignant melanoma, leukaemia, and Hodgkin's lymphoma, if the treatment finished within the last five years
    - other tumours, if the treatment finished within the last twelve months

•     acute cardiac inflammations and insufficiencies;
•     severe heart arrhythmia, including sudden atrial fibrillation with cardiac changes within the last six months;
•     arterial hypertension of 3rd degree with two or more risk factors.